HBMBF (HBM Healthcare Investments) ROE %: -3.16% (As of Mar. 2026)


HBMBF HBM Healthcare Investments Ltd HBMBF
24 GF Score
Price $287.35
! 6 Warning Signs
View Full Analysis

What is HBM Healthcare Investments ROE %?

HBM Healthcare Investments HBMBF 24 ROE % is -3.16% as of Mar. 2026. GuruFocus rates HBMBF with a GF Score™ of 24/100. The stock has 6 warning signs investors should review. Among 1,612 Asset Management companies, HBM Healthcare Investments ranks better than 76.92% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. HBM Healthcare Investments's annualized net income for the quarter that ended in Mar. 2026 was $-74.0 Mil. HBM Healthcare Investments's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $2,340.4 Mil. Therefore, HBM Healthcare Investments's annualized ROE % for the quarter that ended in Mar. 2026 was -3.16%.

The historical rank and industry rank for HBM Healthcare Investments's ROE % or its related term are showing as below:

HBMBF' s ROE % Range Over the Past 10 Years
Min: -7.78   Med: 11.56   Max: 42.01
Current: 16.02

During the past 13 years, HBM Healthcare Investments's highest ROE % was 42.01%. The lowest was -7.78%. And the median was 11.56%.

HBMBF's ROE % is ranked better than
76.92% of 1612 companies
in the Asset Management industry
Industry Median: 6.395 vs HBMBF: 16.02

HBM Healthcare Investments  (OTCPK:HBMBF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-74.036/2340.378
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-74.036 / -70.628)*(-70.628 / 2516.8005)*(2516.8005 / 2340.378)
=Net Margin %*Asset Turnover*Equity Multiplier
=104.83 %*-0.0281*1.0754
=ROA %*Equity Multiplier
=-2.95 %*1.0754
=-3.16 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-74.036/2340.378
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-74.036 / -74.036) * (-74.036 / -70.628) * (-70.628 / 2516.8005) * (2516.8005 / 2340.378)
= Tax Burden * Pretax Margin % * Asset Turnover * Equity Multiplier
= 1 * 104.83 % * -0.0281 * 1.0754
=-3.16 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


HBM Healthcare Investments ROE % Related Terms


HBM Healthcare Investments ROE % Historical Data

* Premium members only.

The historical data trend for HBM Healthcare Investments's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HBM Healthcare Investments ROE % Chart

HBM Healthcare Investments Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.77 -7.80 -0.06 1.11 16.43

HBM Healthcare Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.51 -37.79 60.77 43.04 -3.16

HBMBF vs BLK, BX, KKR: ROE % Comparison

For the Asset Management subindustry, HBM Healthcare Investments's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HBM Healthcare Investments ROE % vs Asset Management Industry

For the Asset Management industry and Financial Services sector, HBM Healthcare Investments's ROE % distribution charts can be found below:

* The bar in red indicates where HBM Healthcare Investments's ROE % falls into.


HBMBF
24GF Score
HBM Healthcare Investments Ltd HBMBF
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HBM Healthcare Investments ROE % Calculation

HBM Healthcare Investments's annualized ROE % for the fiscal year that ended in Mar. 2026 is calculated as

ROE %=Net Income (A: Mar. 2026 )/( (Total Stockholders Equity (A: Mar. 2025 )+Total Stockholders Equity (A: Mar. 2026 ))/ count )
=345.298/( (1862.19+2342.262)/ 2 )
=345.298/2102.226
=16.43 %

HBM Healthcare Investments's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-74.036/( (2338.494+2342.262)/ 2 )
=-74.036/2340.378
=-3.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -3.16% mean?
HBM Healthcare Investments (HBMBF) has a ROE % of -3.16% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on HBM Healthcare Investments and its competitors. According to the industry distribution chart, HBM Healthcare Investments ranks #372 out of 1612 companies in the Asset Management industry, placing it in the top 23.1%.
Is HBM Healthcare Investments' ROE % too high?
HBM Healthcare Investments' current ROE % is -3.16%. Based on the distribution chart, HBM Healthcare Investments ranks #372 out of 1612 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, HBM Healthcare Investments has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does HBM Healthcare Investments' ROE % compare to BLK and BX?
According to the Asset Management industry distribution chart, HBM Healthcare Investments ranks #372 out of 1612 companies for ROE %. This places HBM Healthcare Investments in the top 23% of its industry — outperforming the majority of peers. The industry median ROE % is 6.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Asset Management company?
The median ROE % among Asset Management companies is 6.40, based on 1,612 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on HBM Healthcare Investments and its competitors. For the Asset Management industry, the median ROE % is 6.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HBM Healthcare Investments's current ROE % is -3.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Healthcare Investments stock overvalued right now?
HBM Healthcare Investments (HBMBF) has a current ROE % of -3.16%. The current ROE % is -3.16%. HBM Healthcare Investments' overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For HBM Healthcare Investments (HBMBF), the current ROE % is -3.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HBM Healthcare Investments Business Description

Address Bundesplatz 1, Zug, CHE, 6300
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
24GF Score

Get the complete analysis for HBMBF

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$287.35
Price